GB1302349A - - Google Patents
Info
- Publication number
- GB1302349A GB1302349A GB3793471A GB3793471A GB1302349A GB 1302349 A GB1302349 A GB 1302349A GB 3793471 A GB3793471 A GB 3793471A GB 3793471 A GB3793471 A GB 3793471A GB 1302349 A GB1302349 A GB 1302349A
- Authority
- GB
- United Kingdom
- Prior art keywords
- trans
- pge
- pgf
- compounds
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 abstract 7
- 150000002148 esters Chemical class 0.000 abstract 5
- XEYBRNLFEZDVAW-BRNHSORCSA-N (e)-7-[(1r,2r,3r)-3-hydroxy-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C\CCCC(O)=O XEYBRNLFEZDVAW-BRNHSORCSA-N 0.000 abstract 3
- 101000692466 Bos taurus Prostaglandin F synthase 2 Proteins 0.000 abstract 3
- 150000003180 prostaglandins Chemical class 0.000 abstract 3
- -1 and R 4 is H Chemical group 0.000 abstract 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000219209 Plexaura Species 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1302349 Prostaglandins UPJOHN CO 12 Aug 1971 [15 Sept 1970] 37934/71 Heading C2C The invention comprises novel prostaglandins of the formulµ or racemic compounds of these formulae and the mirror images thereof, wherein R 3 is H or C 1-8 alkyl, and R 4 is H, formyl or C 2-8 alkanoyl, and salts thereof when R 3 is H. Compounds of the Formulµ XIV, XV, XVIII and XIX in which R 4 is H are prepared by isomerizing PGE 2 , PGF 2 α, PGF 2# , 15#-PGE 2 , 15#-PGF 2 α or 15#- PGF 2 # or esters thereof by exposing solution of said PGE and PGF reactants and diaryl sulphides or diaryl disulphides to ultraviolet radiation in the range 3000 to 5000 A‹. 5,6-Trans-PGF 2 and 5,6-trans-15#-PGF 2 or esters thereof may also be prepared by ring carbonyl reduction of 5,6-trans-PGE 2 and 5,6-trans-15#-PGE 2 or esters thereof. Compounds of Formulµ XVI and XX in which R 4 is H are made by the neutral or acidic dehydration of 5,6-trans-PGE 2 and 5,6- trans-15#-PGE 2 or esters thereof. Compounds of the Formulµ XVII and XXI in which R 4 is H are obtained by reacting 5,6-trans-PGE 2 or 5,6-trans-PGA 2 or the corresponding 15# isomers thereof or esters thereof with bases whose water solutions have pHs greater than 10. The free hydroxy groups in the compounds thus obtained may, if desired, be acylated, and any free carboxy groups esterified. 5,6-Trans-15#- PGA 2 may also be obtained by extracting colonies or colony pieces of the marine invertebrate Plexaura homomella (Esper), 1972, forma R. Pharmaceutical compositions, suitable for oral, parenteral, rectal, or topical administration, contain the above novel compounds or salts thereof, in admixture with pharmaceuticallyacceptable carriers. The compounds possess the usual prostaglandin type of activities.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7251170A | 1970-09-15 | 1970-09-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1302349A true GB1302349A (en) | 1973-01-10 |
Family
ID=22108068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3793471A Expired GB1302349A (en) | 1970-09-15 | 1971-08-12 |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5549072B1 (en) |
AU (1) | AU453368B2 (en) |
BE (1) | BE772623A (en) |
DE (1) | DE2144048A1 (en) |
FR (1) | FR2106534B1 (en) |
GB (1) | GB1302349A (en) |
NL (1) | NL7112663A (en) |
PH (4) | PH9363A (en) |
ZA (1) | ZA715163B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05505605A (en) * | 1990-03-19 | 1993-08-19 | アラーガン インコーポレイテッド | Use of 5-transprostaglandin F↓2α as an intraocular pressure-lowering agent |
-
1971
- 1971-08-03 ZA ZA715163A patent/ZA715163B/en unknown
- 1971-08-12 GB GB3793471A patent/GB1302349A/en not_active Expired
- 1971-08-16 AU AU32384/71A patent/AU453368B2/en not_active Expired
- 1971-08-18 PH PH12762*UA patent/PH9363A/en unknown
- 1971-09-02 DE DE19712144048 patent/DE2144048A1/de active Pending
- 1971-09-10 JP JP6979271A patent/JPS5549072B1/ja active Pending
- 1971-09-14 FR FR7133112A patent/FR2106534B1/fr not_active Expired
- 1971-09-15 NL NL7112663A patent/NL7112663A/xx not_active Application Discontinuation
- 1971-09-15 BE BE772623A patent/BE772623A/en not_active IP Right Cessation
-
1974
- 1974-10-15 PH PH16422A patent/PH10941A/en unknown
- 1974-10-15 PH PH16420A patent/PH11686A/en unknown
- 1974-10-17 PH PH16430A patent/PH11850A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU453368B2 (en) | 1974-10-03 |
JPS5549072B1 (en) | 1980-12-10 |
BE772623A (en) | 1972-02-15 |
DE2144048A1 (en) | 1972-03-16 |
PH11686A (en) | 1978-05-19 |
ZA715163B (en) | 1972-04-26 |
FR2106534A1 (en) | 1972-05-05 |
AU3238471A (en) | 1973-02-22 |
PH11850A (en) | 1978-07-28 |
PH9363A (en) | 1975-10-22 |
NL7112663A (en) | 1972-03-17 |
FR2106534B1 (en) | 1979-08-17 |
PH10941A (en) | 1977-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1383083A (en) | Thiazolidine derivatives | |
GB1530389A (en) | Perfumery uses of tricyclodecane derivatives | |
GB1489778A (en) | Process of preparing a stable composition containing a compound of the prostaglandin e group | |
GB1164139A (en) | 6-Aminophenyl- and 6-Acylaminophenyl-4,5-Dihydropyridazones-(3) and their production | |
GB1302349A (en) | ||
GB1216619A (en) | Hydroxy-dibutylphenone stabilisers | |
ES432288A1 (en) | Ergopeptine derivatives | |
IT1068038B (en) | FLUORINATED MEMBRANE AT CATION EXCHANGE AND USE OF ITSELF IN THE ELECTROLYSIS OF ALKALINE METAL HALIDE | |
GB1376886A (en) | Process and composition for inhibiting scale desposition | |
GB1352793A (en) | Detergent composition | |
GB1424341A (en) | Diketoesters | |
GB1383931A (en) | 5-nitroimidazoles and processes for their manufacture | |
GB1429166A (en) | ||
GB1416415A (en) | Biphenyl compounds and their use as light protective agents | |
GB1421250A (en) | Production of alkyl sulphonates | |
GB1360939A (en) | Silver dye bleach process | |
GB1333616A (en) | Indene derivatives | |
GB1385950A (en) | Oil-based compositions inhibited from oxidation | |
GB1365175A (en) | Process for the production of polymers | |
GB1421555A (en) | Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives | |
GB1515614A (en) | Preparation of m-benzoylhydratropic acid and an intermediate therefor | |
ES432238A1 (en) | Analogues of prostanoic acids | |
BE814269A (en) | COMPOSITION OF ACRYLIC ACID STABILIZED BY PHENOLS ALKYL | |
SE7600729L (en) | PROSTAGLAND INFORMATIONS | |
ES427614A1 (en) | 9-Hydroxy prosta-5-cis, 11,13-trans-trienoic acids and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |